Sanford Svai S 4
4 · Rani Therapeutics Holdings, Inc. · Filed Mar 24, 2023
Insider Transaction Report
Form 4
Sanford Svai S
Chief Financial Officer
Transactions
- Tax Payment
Class A Common Stock
2023-03-22$5.95/sh−3,355$19,962→ 119,597 total
Footnotes (2)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on March 22, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the restricted stock units granted to Mr. Sanford on March 22, 2022.
- [F2]Includes 2,214 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 1, 2022.